Panacea Life Sciences Holdings, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for the quarter ending 2023-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $23.10K, a 34.01% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for fiscal 2023 was $23.10K, a 58.01% decline from fiscal 2022.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for fiscal 2022 was $55.00K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for fiscal 2020 was $378.52K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, issued for services for fiscal 2018 was $26.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $23.10K 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $23.10K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-06-30 | $23.10K 10-Q · filed 2023-08-15 | $23.10K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-04-01 | $35.00K derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $55.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-06-30 | $35.00K 10-Q · filed 2023-08-15 | |
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-12 | |
| 2020-12-31 | $378.52K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | $70.58K 10-Q · filed 2020-11-18 | |
| 2020-03-31 | $378.52K 10-Q/A · filed 2021-05-27 | |
| 2019-09-30 | $57.26K 10-Q · filed 2020-11-18 | |
| 2019-06-30 | $19.50K 10-Q · filed 2020-11-18 | |
| 2019-03-31 | $891.80K 10-Q · filed 2019-08-14 | |
| 2018-12-31 | $26.00K 10-K · filed 2020-05-22 | |
| 2016-12-31 | $1.00M 10-K · filed 2018-04-02 |